Richard Kenney

Richard Kenney

President at
ClinReg Biologics LLC
68 year
Health Technology
Consumer Services
Commercial Services

Profile

Richard T.
Kenney
is currently President at ClinReg Biologics LLC since 2016.
Also holds memberships at the American Federation for Medical Research and the American Society of Tropical Medicine & Hygiene.
Formerly Senior Director-Global Clinical at ID Biomedical Corp.
(2009), Vice President-Clinical Development at Vical, Inc. (2010-2012), Chief Medical Officer at Marker Therapeutics, Inc., Vice President-Medical & Regulatory Affairs at Valneva Usa, Inc. (2005), Chief Medical Officer at Janssen Vaccines & Prevention BV (2012-2013), Principal at US Food & Drug Administration, Chief Medical Officer at Immune Design Corp.
(2013-2016), Chief Development Officer at X-Vax Technology, Inc. (2017-2021), and Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc. (2021-2025).
Education includes undergraduate degree from George Washington University and doctorate from Harvard Medical School.

Richard Kenney active positions

CompaniesPositionStart
Corporate Officer/Principal -
Corporate Officer/Principal -
President 31/08/2016

Former positions of Richard Kenney

CompaniesPositionEnd
SONNET BIOTHERAPEUTICS Chief Tech/Sci/R&D Officer 01/12/2025
Corporate Officer/Principal 31/01/2021
IMMUNE DESIGN CORP Chief Tech/Sci/R&D Officer 15/06/2016
Chief Tech/Sci/R&D Officer 31/07/2013
Chief Tech/Sci/R&D Officer -
See the detail of Richard Kenney's experience

Training of Richard Kenney

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

42

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Government

Commercial Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Richard Kenney
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!